Nexien BioPharma Inc (NXEN)

[Renegades17]

There's very little free float

I doubt there can be much volume. I own a lot and won't sell any for a while. There's too many catalysts upcoming. The majority of the shares outstanding are tied up by insiders and investors in Intiva prior to the reverse merger. I doubt they are selling anytime soon either given the projects in the pipeline.

I think CBD based drug development will be one of the major investment themes for 2018 and beyond. There are only a handful of legitimate ways to play this theme, IMO, and NTVA will become one of the primary ones in 2018.